BUFFALO, NY — September 10, 2026 — A new case report was published in Volume 13 of Oncoscience on August 12, 2026, titled “Pembrolizumab-associated Coombs-negative autoimmune hemolytic anemia in metastatic lung adenocarcinoma with concurrent thromboembolism and bacteremia: A case report with literature review.”

Researchers at Johns Hopkins Medicine have demonstrated a new approach to brain imaging that enables continuous monitoring of brain activity and the physiologic changes associated with neurological disease progression for more than 24 hours in freely moving mouse models. The cloud-based miniaturized microscope, called CloudScope, operates autonomously and allows scientists to access live imaging data remotely from anywhere in the world, creating new opportunities to study diseases as they develop over time.

This technology is a saliva-based assay to rapidly, accurately, and non-invasively assess flavivirus immunity by measuring various antibody classes present in saliva.

This technology combines PKZ18-22, the most promising analog, with antibiotics from multiple different classes. This synergy provides up to an 8-fold increase in efficacy of aminoglycosides when a small amount of PKZ18-22 is added.

This DNA nanoswitch technology, developed at the University at Albany, is useful in a range of RNase sensing applications. The nanoswitch is initially locked in a looped state by an RNA strand. In the presence of an RNase, the RNA strand is cleaved, and the nanoswitch changes shape into the linear state. 

An international team of researchers led by the University Hospital and University of Bonn, as well as the universities of Edinburgh, Basel and Pennsylvania, has identified a previously unrecognized form of inherited retinal degeneration caused by a specific variant in the EFEMP1 gene. The disease primarily affects the peripheral retina and the rod photoreceptors responsible for vision in dim light and darkness. Importantly, rod function may already be severely impaired while the retina still appears largely normal on clinical examination. The results of the study have now been published in the journal JAMA Ophthalmology.